Amelioration of Cystic Fibrosis Intestinal Mucous Disease in Mice by Restoration of mCLCA3

Gastroenterology

Volumn 133, Issue 6, 2007, Pages

  Young, Fiona D ^a,b   Newbigging, Susan ^b,c   Choi, Caroline ^d   Keet, Mary ^a,b   Kent, Geraldine ^a   Rozmahel, Richard F ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBULAR PROTEIN; MURINE ORTHOLOGUE OF HUMAN HCLCA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL HYPERPLASIA; CELL SURVIVAL; CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTROPHYSIOLOGY; GOBLET CELL; HYPERTROPHY; INTESTINE MUCOSA; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN SECRETION;

EID: 36549014212     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.10.007     Document Type: Article

References (49)

1. Welsh M.J., Ramsey B.W., Accurso F.J., et al. Cystic fibrosis. In: Scriver C.R., Valle D., and Sly W.S. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. (2001), McGraw-Hill Inc, New York, NY 521-588
2. Barrett K.E., and Keely S.J. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 62 (2000) 535-572
3. Riordan J.R., Rommens J., Kerem B., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
4. Anderson M.P., Gregory R.J., Thompson S., et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253 (1991) 202-205
5. - channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J Biol Chem 266 (1991) 19142-19145
6. Vankeerberghen A., Cuppens H., and Cassiman J.J. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros 1 (2002) 13-29
7. Mehta A. CFTR: more than just a chloride channel. Pediatr Pulmonol 39 (2005) 292-298
8. Guilbault C., Novak J.P., Martin P., et al. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls. Physiol Genomics 25 (2006) 179-193
9. Norkina O., Kaur S., Ziemer D., et al. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286 (2004) G1032-G1041
10. Bensalem N., Ventura A.P., Vallee B., et al. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 4 (2005) 1591-1601
11. Xu Y., Liu C., Clark J.C., et al. Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(δ508) in the lung. J Biol Chem 281 (2006) 11279-11291
12. Xu Y., Clark J.C., Aronow B.J., et al. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278 (2003) 7674-7682
13. Brouillard F., Bensalem N., Hinzpeter A., et al. Blue native/SDS-PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice. Mol Cell Proteomics 4 (2005) 1762-1775
14. Leverkoehne I., Holle H., Anton F., et al. Differential expression of calcium-activated chloride channels (CLCA) gene family members in the small intestine of cystic fibrosis mouse models. Histochem Cell Biol 126 (2006) 239-250
15. - channel proteins. Genomics 54 (1998) 200-214
16. Gandhi R., Elble R.C., Gruber A.D., et al. Molecular and functional characterization of a calcium-sensitive chloride channel from mouse lung. J Biol Chem 273 (1998) 32096-32101
17. Gruber A.D., Schreur K.D., Ji H.L., et al. Molecular cloning and transmembrane structure of hCLCA2 from human lung, trachea, and mammary gland. Am J Physiol 276 (1999) C1261-C1270
18. Romio L., Musante L., Cinti R., et al. Characterization of a murine gene homologous to the bovine CaCC chloride channel. Gene 228 (1999) 181-188
19. Loewen M.E., and Forsyth G.W. Structure and function of CLCA proteins. Physiol Rev 85 (2005) 1061-1092
20. Loewen M.E., Bekar L.K., Walz W., et al. pCLCA1 lacks inherent chloride channel activity in an epithelial colon carcinoma cell line. Am J Physiol Gastrointest Liver Physiol 287 (2004) G33-G41
21. Gibson A., Lewis A.P., Affleck K., et al. hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels. J Biol Chem 280 (2005) 27205-27212
22. Mundhenk L., Alfalah M., Elble R.C., et al. Both cleavage products of the mCLCA3 protein are secreted soluble proteinss. J Biol Chem 281 (2006) 30072-30080
23. Pawlowski K., Lepisto M., Meinander N., et al. Novel conserved hydrolase domain in the CLCA family of alleged calcium-activated chloride channels. Proteins 63 (2006) 424-439
24. Leverkoehne I., and Gruber A.D. The murine mCLCA3 (alias gob-5) protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J Histochem Cytochem 50 (2002) 829-838
25. Nakanishi A., Morita S., Iwashita H., et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 98 (2001) 5175-5180
26. Hoshino M., Morita S., Iwashita H., et al. Increased expression of the human Ca2+-activated Cl- channel 1 (CaCC1) gene in the asthmatic airway. Am J Respir Crit Care Med 165 (2002) 1132-1136
27. Robichaud A., Tuck S.A., Kargman S., et al. Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthma. Am J Respir Cell Mol Biol 33 (2005) 303-314
28. Patel A.C., Morton J.D., Kim E.Y., et al. Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members. Physiol Genomics 25 (2006) 502-513
29. Snouwaert J.N., Brigman K.K., Latour A.M., et al. An animal model for cystic fibrosis made by gene targeting. Science 257 (1992) 1083-1088
30. Kent G., Iles R., Bear C.E., et al. Lung disease in mice with cystic fibrosis. J Clin Invest 100 (1997) 3060-3069
31. Sweetser D.A., Hauft S.M., Hoppe P.C., et al. Transgenic mice containing intestinal fatty acid-binding protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of the reporter gene in their small intestine. Proc Natl Acad Sci U S A 85 (1988) 9611-9615
32. Roth K.A., Hermiston M.L., and Gordon J.I. Use of transgenic mice to infer the biological properties of small intestinal stem cells and to examine the lineage relationships of their descendants. Proc Natl Acad Sci U S A 88 (1991) 9407-9411
33. Zhou L., Dey C.R., Wert S.E., et al. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 266 (1994) 1705-1708
34. Rozmahel R., Wilschanski M., Matin A., et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 12 (1996) 280-287
35. O'Neal W.K., Hasty P., McCray P.J., et al. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet 2 (1993) 1561-1569
36. Ratcliff R., Evans M.J., Cuthbert A.W., et al. Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet 4 (1993) 35-41
37. De Lisle R.C., Roach E.A., and Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr 42 (2006) 46-52
38. Grubb B.R., and Gabriel S.E. Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis. Am J Physiol 273 (1997) G258-G266
39. Gyomorey K., Rozmahel R., and Bear C.E. Amelioration of intestinal disease severity in cystic fibrosis mice is associated with improved chloride secretory capacity. Pediatr Res 48 (2000) 731-734
40. Komiya T., Tanigawa Y., and Hirohashi S. Cloning and identification of the gene gob-5, which is expressed in intestinal goblet cells in mice. Biochem Biophys Res Commun 255 (1999) 347-351
41. Loewen M.E., Gabriel S.E., and Forsyth G.W. The calcium-dependent chloride conductance mediator pCLCA1. Am J Physiol Cell Physiol 283 (2002) C412-C421
42. Gruber A.D., Elble R.C., and Pauli B.U. Calcium-activated chloride channels. In: Fuller C.M. (Ed). Current topics in membranes Volume 53 (2002), Academic Press, San Diego, CA
43. Long A.J., Sypek J.P., Askew R., et al. Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation. Am J Respir Cell Mol Biol 35 (2006) 357-365
44. Anton F., Leverkoehne I., Mundhenk L., et al. Overexpression of eCLCA1 in small airways of horses with recurrent airway obstruction. J Histochem Cytochem 53 (2005) 1011-1021
45. Sabo-Attwood T., Ramos-Nino M., Bond J., et al. Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis. Am J Pathol 167 (2005) 1243-1256
46. Hauber H.P., Tsicopoulos A., Wallaert B., et al. Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction. Eur Respir J 23 (2004) 846-850
47. Yasuo M., Fujimoto K., Tanabe T., et al. Relationship between calcium-activated chloride channel 1 and MUC5AC in goblet cell hyperplasia induced by interleukin-13 in human bronchial epithelial cells. Respiration 73 (2006) 347-359
48. Zhou Y., Shapiro M., Dong Q., et al. A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Novartis Found Symp 248 (2002) 150-170 277-282
49. Hauber H.P., Manoukian J.J., Nguyen L.H., et al. Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Laryngoscope 113 (2003) 1037-1042